These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28043540)

  • 21. Screening outcomes from patients with suspected multidrug-resistant tuberculosis: lessons learned in the Philippines.
    Gler MT; Guilatco RS; Guray CV; Tupasi TE
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1326-30. PubMed ID: 22863522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Factors related to the occurrence of multi- (extensively-) drug resistant tuberculosis (M/XDR-TB) in our hospital].
    Okumura M; Yoshiyama T; Ogata H; Morimoto K; Kokuto H; Kurashima A; Kudoh S
    Kekkaku; 2011 Nov; 86(11):863-8. PubMed ID: 22250465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
    Tadesse M; Aragaw D; Dimah B; Efa F; Abebe G
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S48-S49. PubMed ID: 28043605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug resistant tuberculosis].
    Zwolska Z; Augustynowicz-Kopeć E
    Pol Merkur Lekarski; 2011 May; 30(179):362-6. PubMed ID: 21675144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics?
    Dubrovina I; Miskinis K; Lyepshina S; Yann Y; Hoffmann H; Zaleskis R; Nunn P; Zignol M
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):756-62. PubMed ID: 18544200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Research and control of relapse tuberculosis cases].
    Yamagishi F; Toyota M
    Kekkaku; 2009 Dec; 84(12):767-8. PubMed ID: 20077861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiological signs associated with pulmonary multi-drug resistant tuberculosis: an analysis of published evidences.
    Wáng YXJ; Chung MJ; Skrahin A; Rosenthal A; Gabrielian A; Tartakovsky M
    Quant Imaging Med Surg; 2018 Mar; 8(2):161-173. PubMed ID: 29675357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The use of nationwide tuberculosis surveillance system data to determine geographical differences in drug resistance--consideration of the representativeness of the drug resistance rate in Japan].
    Ohmori M; Ito K; Uchimura K; Yamauchi Y; Shimouchi A; Yoshiyama T; Mitarai S; Ishikawa N
    Kekkaku; 2011 Jul; 86(7):729-35. PubMed ID: 21922783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tuberculosis prevalence survey in Japan].
    Shimao T
    Kekkaku; 2009 Nov; 84(11):713-20. PubMed ID: 19999593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [How to cope with the global tuberculosis burden--experiences and perspectives for Japan's international cooperation].
    Ishikawa N
    Kekkaku; 2005 Feb; 80(2):89-94. PubMed ID: 15920981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-tuberculosis drug resistance pattern among pulmonary tuberculosis patients with or without HIV infection in Mwanza, Tanzania.
    Range N; Friis H; Mfaume S; Magnussen P; Chanualucha J; Kilale A; Mugomela A; Andersen AB
    Tanzan J Health Res; 2012 Oct; 14(4):243-9. PubMed ID: 26591721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multidrug-resistant tuberculosis].
    Saito H; Amitani R
    Kekkaku; 1998 Nov; 73(11):645-7. PubMed ID: 9866926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China.
    Liang L; Wu Q; Gao L; Hao Y; Liu C; Xie Y; Sun H; Yan X; Li F; Li H; Fang H; Ning N; Cui Y; Han L
    Thorax; 2012 Jul; 67(7):632-8. PubMed ID: 22403070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Trends in tuberculosis infection among foreigners in Japan according to work status].
    Hoshino H; Ohmori M; Okada M
    Kekkaku; 2010 Sep; 85(9):697-702. PubMed ID: 20960949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis.
    Teixeira L; Perkins MD; Johnson JL; Keller R; Palaci M; do Valle Dettoni V; Canedo Rocha LM; Debanne S; Talbot E; Dietze R
    Int J Tuberc Lung Dis; 2001 Apr; 5(4):321-8. PubMed ID: 11334250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary drug resistance to anti-tuberculosis drugs in major towns of Amhara region, Ethiopia.
    Yimer SA; Agonafir M; Derese Y; Sani Y; Bjune GA; Holm-Hansen C
    APMIS; 2012 Jun; 120(6):503-9. PubMed ID: 22583363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of multidrug-resistant tuberculosis in a community-based directly observed treatment programme in rural South Africa.
    Davies GR; Pillay M; Sturm AW; Wilkinson D
    Int J Tuberc Lung Dis; 1999 Sep; 3(9):799-804. PubMed ID: 10488888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.